$CMMB
Chemomab Therapeutics Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Tel Aviv
CMMB chart
What traders are saying about $CMMB
Latest postsChemomab Therapeutics Ltd. news
- Primary Sclerosing Cholangitis Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma
StreetInsider ·
- Chemomab Therapeutics Ltd. Estimates – NASDAQ:CMMB
TradingView ·
- Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
Yahoo Finance ·
- Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
Yahoo Finance ·
- Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
Yahoo Finance ·
- Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
Yahoo Finance ·
- Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
Yahoo Finance ·
- Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
Yahoo Finance ·
Chemomab Therapeutics Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$9.0M | -$13.9M | -$24.2M | -$27.6M |
| Diluted EPS | $0.02 | $0.04 | $0.10 | $0.12 |
| Total assets (year end) | $13.8M | $17.0M | $22.2M | $43.1M |
| Cash and equivalents (year end) | $7.6M | $6.1M | $9.3M | $13.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Chemomab Therapeutics Ltd.
- Ticker
- CMMB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1534248
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
Frequently asked questions
What exchange is Chemomab Therapeutics Ltd. listed on?
Chemomab Therapeutics Ltd. trades on the Nasdaq under the ticker symbol CMMB.
What industry is Chemomab Therapeutics Ltd. in?
Chemomab Therapeutics Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Chemomab Therapeutics Ltd. headquartered?
Chemomab Therapeutics Ltd.'s business address on file with the SEC is in Tel Aviv.
When does Chemomab Therapeutics Ltd.'s fiscal year end?
Chemomab Therapeutics Ltd.'s fiscal year ends on December 31.